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Abstract 
The aim of our study was to evaluate the immunohisto-
chemical expression of Bcl-2 and Bax protein in optic nerve
axons after severe eyeball injury and in the eyes with absolute
glaucoma. A series of 19 eyeballs, enucleated because of
absolute glaucoma and 41 eyeballs, enucleated, following
extensive injury, at the Department of Ophthalmology of the
Medical University of Bialystok, were taken into our study. The
immunohistochemical reaction was performed with Bcl-2 and
Bax protein antibodies and by the LSAB technique. DAB was
used in order to visualise the reaction. The optic nerve axons in
glaucomatous eyeballs showed statistically significant higher
Bax protein expressions than those of Bcl-2 proteins. In the
optic nerve axons after severe eyeball injury,  a non-significant-
ly higher Bcl-2 protein expression was observed.
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Introduction 
Almost all body cells have a capacity to undergo a pro-
grammed cell death process. They differ in the ease with which
they are able to initiate apoptosis. The tendency to initiate apop-
tosis and the speed with which this program is triggered depend
on the type of cells and their stage of development. Cells, which
are difficult to replace, including neurons of the developed ner-
vous system, undergo apoptosis with some difficulty. Neverthe-
less, under normal physiological conditions, the average person
loses 10000 retinal ganglion cells annually, due to apoptosis [1,
2, 3]. Proteins from the Bcl-2 family play a major role in apop-
tosis regulation at its decisive stage [4, 5, 6]. There are few stud-
ies, concerning apoptotic protein expression in human retinal
ganglion cells in pathological states [7, 8]. It is not known how
Bcl-2 and Bax protein expressions change in posttraumatic con-
ditions. Glaucomatous optic neuropathy is multifactorial in eti-
ology. Both mechanical and vasogenic theories remain viable
explanations for the observed nerve damage and the destructive
effect of trophic withdrawal could be espoused by either theory.
Each theory feeds into the final common pathway of cell death
by apoptosis [9, 10]. The aim of our study was an immunohis-
tochemical evaluation of Bcl-2 and Bax protein expression in
the optic nerve axons in eyeballs after severe trauma and in the
eyes with absolute glaucoma.
Material and methods 
We examined a series of 41 eyeballs, which were enucleat-
ed, following extensive injury over the period between 1991 and
2003 and a series of 19 eyeballs from patients with absolute
glaucoma, suffering from severe ophthalmalgia treated of neces-
sity by enucleation during the same period at the Department of
Ophthalmology of the Medical University of Bialystok. After
enucleation, the eyeballs were fixed in a 10% buffered formalin
solution, embedded in paraffin at 56°C, then cut into 5µm slices
and stained with hematoxylin and eosin (H+E). The evaluation
of Bcl-2 and Bax protein expression was performed by the
immunohistochemical reaction, using monoclonal antibodies
from The Santa Cruz Biochemicals and DAKO (Bax No P-19,
sc-526, DAKO/Bcl-2 No MO887) and LSAB technique. The
IgG1 kappa antibody was used as a negative control, whereas
samples of breast cancer tissue, which showed a strong positive
Bcl-2 and Bax protein expression in human optic nerve
axons in the eyeballs after severe trauma and in the eyes
with absolute glaucoma
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The estimation of immunostaining was done under a light
microscope in representative fields, using a lens with a magnifi-
cation of 20x in the optic nerve axons and sections were
obtained from the retrolaminar region of the optic nerve head.
The criteria for a positive reaction were as follows: (++) above
50% of axons of the field was showing positive immunostain-
ing, (+) between 50%-10% and (-) below 10% of cells with pos-
itive immunostaining. We analyzed Bcl-2 and Bax protein
expressions in relation to the patients age, sex and the relation-
ships between the examined markers in both groups, as well as
Bcl-2 and Bax protein expressions in relation to the time,
elapsed from trauma to enucleation and to the type of injury.
The obtained results were statistically analyzed, using Fisher
and Chi-square tests. Differences at p<0.05 were considered sta-
tistically significant.
Results 
The group of trauma patients: the series of 41 examined eye-
balls came from male patients, aged between 18 and 77 years
(the mean age: 45 years, SD±17,8). In 23 cases, we observed
ruptured globes, secondary to severe blunt trauma. In 18 cases,
the eye injury was caused by a sharp tool (severe corneal and
scleral lacerations). All the injured and ruptured eyes were
blind. In 13 patients, enucleation was performed on the day of
trauma or 1 day post-injury (Group I), in 20 cases,  2-16 days
post injury (Group II), and in 8 patients - 1 month till 4 years
after trauma (Group III). Bcl-2 and Bax protein expressions
were observed in cellular cytoplasm. The analysis of Bcl-2 and
Bax protein expression in closed and perforating injury groups
is shown in Table 1.   In the entire trauma group, the mean age
of patients without Bcl-2 protein expression in the optic nerve
axons was 34.44±18.6 years and was lower than the mean age
of patients with Bcl-2 overexpression: 49.04±19.78 years
(p=0,065). Bcl-2 protein expression was stronger than Bax
expression (statistically non-significant) in the group of trauma
patients. In 92.3% patients with enucleation on the day of trau-
ma, or 1 day post-trauma, Bcl-2 protein expression was
observed, Bax in 61.5%. In the group with enucleation, 2-16
days post- injury, 60% cases showed Bcl-2 positive expression
and Bax 50%. In the 1 month-4 years enucleation post-trauma
group, Bcl-2 expression was observed in 87.5% cases, Bax in
62.5%. Bcl-2 and Bax expression did not correlate with the time
period from severe trauma to eye enucleation. Bcl-2 protein
expression did not correlate with Bax protein expression (Bcl-
2/Bax p=0.445).
The group of glaucoma patients: the series of 19 examined
eyeballs came from male patients (11) and female patients (8),
aged between 21 and 86 years (the mean age: 59.7 years,
SD±19.7). In the group of glaucoma patients without Bcl-2
expression, the mean age was 70.1±17 years and was statistical-
ly higher than the mean age of patients with Bcl-2 protein over-
expression (53.7±18.8 years). Bax protein expression was sta-
tistically significantly stronger in the optic nerve axons than
Bcl-2 one: Bax/Bcl-2 (p=0.0007) and correlated with Bcl-2
expression: p=0.0155. In the group of glaucoma patients, Bcl-2
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Type of injury 
Closed injury  Perforating injury 
Protein 
expression 
%  Number  %  Number 
 
p value 
Bcl-2 (-)  8,7  2  44,4  8 
Bcl-2 (+)  60,9  14  50  9 
Bcl-2 (++)  30,4  7  5,6  1 
p= 0,012 
Bax (-)  34,8  8  55,6  10 
Bax (+)  47,8  11  27,8  5 
Bax (++)  57,1  4  16,7  3 
p= 0,36 
Table 1. Correlations between examined marker expressions and the type of injury
Figure 1. Cytoplasmatic Bcl-2 protein immunostaining in the
optic nerve axons after severe eyeball injury (mag.x200).
Figure 2. Cytoplasmatic Bax protein immunostaining in the
optic nerve axons after severe eyeball injury 
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and Bax expressions did not depend on sex. The trauma group
consisted of male patients only. Bcl-2 and Bax expressions did
not correlate with the age in either of the groups.
Discussion 
Up until 1993, apoptosis had not been taken into consider-
ation in the studies on the pathogenesis of nerve-related dis-
eases. Disorders of apoptosis have widely been discussed in
the literature with regards to neoplastic process [1, 11, 12]. A
different situation is observed in cases of posttraumatic retinal
detachment and glaucomatous optic neuropathy. A pathologi-
cal intensification of apoptosis takes place, manifesting itself
in retinal nerve cell damage and their axons, leading to sight
loss [13, 14]. In our study, in the glaucomatous optic nerve
axons, proapoptotic protein expression dominated, what might
confirm the apoptotic nerve damage theory. The small per-
centage of statistically older glaucomatous patients with Bcl-2
protein positivity might be a proof for the proapoptotic ten-
dency, even though,  physiologically, a decreased apoptosis
process is observed in the course of  aging. The correlation
Bcl-2 protein expression with Bax protein expression suggest-
ed a possibility of Bcl-2/Bax heterodimer creation and contin-
uation of programmed cell death in the optic nerve axons,
despite the absolute functional damage of the optic nerve.
Our study showed the expression of Bcl-2 protein to be
more significant in the closed injury type group than in the
perforating injury group. Bcl-2 protein expression was
observed mainly in cases of older people. It is believed that
older organisms lose their ability to induce apoptosis. In the
whole group of trauma patients, a domination of Bcl-2 protein
expression was observed. It was not statistically significant,
however, it might be suggestive of some protection mechanism
in the optic nerve axons after eye trauma. The results of our
study might provoke thinking that, in the stage of absolute
glaucoma in the optic nerve axons, proapoptotic Bax protein
expression dominated, what is concordant with the apoptotic
theory of glaucomatous optic neuropathy. Bcl-2 dominance in
the optic nerve axons after severe eyeball trauma might sug-
gest posttraumatic neuroprotection tendency in the optic
nerve.
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